GSK126

TargetMol
Product Code: TAR-T2079
Supplier: TargetMol
CodeSizePrice
TAR-T2079-2mg2mg£100.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2079-5mg5mg£118.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2079-1mL1 mL * 10 mM (in DMSO)£125.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2079-10mg10mg£143.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2079-25mg25mg£194.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2079-50mg50mg£262.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2079-100mg100mg£366.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2079-200mg200mg£455.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
GSK126 is a excellently specific EZH2 methyltransferase inhibitor ( IC50=9.9 nM).
CAS:
1346574-57-9
Formula:
C31H38N6O2
Molecular Weight:
526.67
Pathway:
Chromatin/Epigenetic
Purity:
0.9967
SMILES:
CC[C@H](C)n1cc(C)c2c(cc(cc12)-c1ccc(nc1)N1CCNCC1)C(=O)NCc1c(C)cc(C)[nH]c1=O
Target:
Histone Methyltransferase

References

1. McCabe MT, et al. Nature. 2012, 492(7427), 108-112. 2. Ott HM, et al. Mol Cancer Ther. 2014, 13(12), 3062-3073. 3. Takeshima H, et al. Carcinogenesis. 2015, 36(2), 192-201. 4. Huang H, Wu D, Yan Y, et al. A targetable epigenetic vulnerability in PI3K/AKT inhibitor resistant cancers[J]. bioRxiv. 2020 5. Wu D, Yan Y, Wei T, et al. An acetyl-histone vulnerability in PI3K/AKT inhibition-resistant cancers is targetable by both BET and HDAC inhibitors[J]. Cell Reports . 2021, 34(7): 108744.